February 7, 2022
Summary: Learn about recent efforts in glioblastoma where we are combining innovative trial designs with the use of external data to streamline evidence generation for new medicine development. Panelists will discuss the need for innovation in clinical trials, navigating regulatory requirements in clinical evidence generation, considerations in selecting and using external data to support decision making, and why glioblastoma is an ideal use case.
Moderator: Bill Louv, PhD, Interim CEO, CEO Roundtable on Cancer and President, Project Data Sphere
Speakers:
- Jacob Sands, MD, Instructor of Medicine, Dana-Farber Cancer Institute
- Frank Rockhold, PhD, Professor of Biostatistics, Duke University
- Lorenzo Trippa, PhD, Associate Professor of Biostatistics, Dana-Farber Cancer Institute
- Rif Rahman, MD Assistant Professor of Radiation Oncology, Brigham and Women's Hospital